Literature DB >> 12913188

Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome.

J R Connor1, P J Boyer, S L Menzies, B Dellinger, R P Allen, W G Ondo, C J Earley.   

Abstract

OBJECTIVE: To assess neuropathology in individuals with restless legs syndrome (RLS).
METHODS: A standard neuropathologic evaluation was performed on seven brains from individuals who had been diagnosed with RLS. The substantia nigra was examined in greater detail for iron staining and with immunohistochemistry for tyrosine hydroxylase and proteins involved in iron management. Five age-matched individuals with no neurologic history served as controls.
RESULTS: There were no histopathologic abnormalities unique to the RLS brains. Tyrosine hydroxylase staining in the major dopaminergic regions appeared normal in the RLS brains. Iron staining and H-ferritin staining was markedly decreased in the RLS substantia nigra. Although H-ferritin was minimally detected in the RLS brain, L-ferritin staining was strong. However, the cells staining for L-ferritin in RLS brains were morphologically distinct from those in the control brains. Transferrin receptor staining on neuromelanin-containing cells was decreased in the RLS brains compared to normal, whereas transferrin staining in these cells was increased.
CONCLUSIONS: RLS may not be rooted in pathologies associated with traditional neurodegenerative processes but may be a functional disorder resulting from impaired iron acquisition by the neuromelanin cells in RLS. The underlying mechanism may be a defect in regulation of the transferrin receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12913188     DOI: 10.1212/01.wnl.0000078887.16593.12

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  122 in total

1.  Investigation of unmedicated early onset restless legs syndrome by voxel-based morphometry, T2 relaxometry, and functional MR imaging during the night-time hours.

Authors:  P N Margariti; L G Astrakas; S G Tsouli; G M Hadjigeorgiou; S Konitsiotis; M I Argyropoulou
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-15       Impact factor: 3.825

Review 2.  Iron for restless legs syndrome.

Authors:  Lynn M Trotti; Srinivas Bhadriraju; Lorne A Becker
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

Review 3.  Effects of opiates and HIV proteins on neurons: the role of ferritin heavy chain and a potential for synergism.

Authors:  Lindsay Festa; Olimpia Meucci
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581

4.  Neuromelanin and iron in human locus coeruleus and substantia nigra during aging: consequences for neuronal vulnerability.

Authors:  F A Zucca; C Bellei; S Giannelli; M R Terreni; M Gallorini; E Rizzio; G Pezzoli; A Albertini; L Zecca
Journal:  J Neural Transm (Vienna)       Date:  2006-04-28       Impact factor: 3.575

Review 5.  Management of restless legs syndrome in patients on dialysis.

Authors:  Miklos Z Molnar; Marta Novak; Istvan Mucsi
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 6.  [Iron deficiency, Fatigue and Restless-Legs-Syndrome].

Authors:  Bettina Wurzinger; Peter König
Journal:  Wien Med Wochenschr       Date:  2016-08-30

Review 7.  Animal models of sleep disorders.

Authors:  Linda A Toth; Pavan Bhargava
Journal:  Comp Med       Date:  2013-04       Impact factor: 0.982

8.  Iron-deficiency and dopaminergic treatment effects on RLS-Like behaviors of an animal model with the brain iron deficiency pattern of the restless legs syndrome.

Authors:  Richard P Allen; Christopher J Earley; Byron C Jones; Erica L Unger
Journal:  Sleep Med       Date:  2020-02-05       Impact factor: 3.492

9.  Genomewide linkage scan identifies a novel susceptibility locus for restless legs syndrome on chromosome 9p.

Authors:  Shenghan Chen; William G Ondo; Shaoqi Rao; Lin Li; Qiuyun Chen; Qing Wang
Journal:  Am J Hum Genet       Date:  2004-04-07       Impact factor: 11.025

Review 10.  Parkinson disease: an update.

Authors:  Steven J Frucht
Journal:  Neurologist       Date:  2004-07       Impact factor: 1.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.